title: Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial".
authors.affiliation: LVTS, INSERM-Unité 1148, Paris, France.
authors.forename: P Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Robert A
authors.initials: RA
authors.lastname: Harrington
authors.forename: Håkan
authors.initials: H
authors.lastname: Emanuelsson
authors.forename: Hugo A
authors.initials: HA
authors.lastname: Katus
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Mahaffey
authors.forename: Bernhard
authors.initials: B
authors.lastname: Meier
authors.forename: Robert F
authors.initials: RF
authors.lastname: Storey
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Wojdyla
authors.forename: Basil S
authors.initials: BS
authors.lastname: Lewis
authors.forename: Gerald
authors.initials: G
authors.lastname: Maurer
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.forename: Stefan K
authors.initials: SK
authors.lastname: James
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000241:Adenosine / Q000031:analogs & derivatives*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D038622:Internationality; D008297:Male; D015607:Stents / Q000009:adverse effects*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D000241:Adenosine; D013988:Ticlopidine